Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Arvind Kaimal
An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir
BMC Infectious Diseases
Infectious Diseases
Related publications
PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia: An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Lopinavir/Ritonavir Monotherapy After Virologic Failure of First-Line Antiretroviral Therapy in Resource-Limited Settings
AIDS
Infectious Diseases
Allergy
Immunology
Lack of Effect From a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir
Pharmacotherapy
Pharmacology
Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial
Journal of the International Association of Providers of AIDS Care
Dermatology
Infectious Diseases
Immunology
Virological Failure and Predictors in Patients With Clinical and Immunological Failures to First-Line ARV Regimens in Vietnam
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-positive Patients Ingesting Dabigatran
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
